View in EDS

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study.

Saved in:
Bibliographic Details
Title: Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study.
Authors: Meireles AM; Department of Hematology and Bone Marrow Transplantation, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Clinical Oncology Group, IPO Porto Research Center (CI-IPOP), Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal. Electronic address: ana.maria.meireles@ipoporto.min-saude.pt., Calisto R; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal; Population Studies Department. School of Medicine and Biomedical Sciences, ICBAS, University of Porto, Portugal Epidemiology Service, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal., Bento MJ; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal; Population Studies Department. School of Medicine and Biomedical Sciences, ICBAS, University of Porto, Portugal Epidemiology Service, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal., Gouveia PM; Unidade Local de Saúde Santo António, Porto, Portugal., Bizarro S; Oncogenetics Group, IPO Porto Research Center (CI-IPOP), Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal., Teixeira M; Oncogenetics Group, IPO Porto Research Center (CI-IPOP), Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal., Moreira C; Department of Hematology and Bone Marrow Transplantation, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Clinical Oncology Group, IPO Porto Research Center (CI-IPOP), Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal., Santo AE; Department of Hematology and Bone Marrow Transplantation, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Clinical Oncology Group, IPO Porto Research Center (CI-IPOP), Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal., Mariz M; Department of Hematology and Bone Marrow Transplantation, Instituto Português de Oncologia do Porto (IPO Porto), Porto, Portugal; Group of Epidemiology, Results, Economy and Management in Oncology - Research Center, Porto Comprehensive Cancer Center (Porto. CCC) & RISE@CI-IPOP (Health Research Network), Porto, Portugal.
Source: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2025 Jul-Sep; Vol. 47 (3), pp. 103935. Date of Electronic Publication: 2025 Jul 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2531-1387
DOI:10.1016/j.htct.2025.103935